A new radioactive tracer for positron emission tomography (PET) myocardial perfusion imaging will soon be available in the United States, and it’s expected to facilitate substantial growth in such ...
A novel tracer for positron emission tomography (PET) myocardial perfusion imaging, called flurpiridaz F-18, performed well in a second phase III trial when it came to the detection of CAD in patients ...
The emerging advantages of positron-emission tomography (PET) myocardial perfusion imaging (MPI) for coronary artery disease (CAD) diagnosis and assessment of cardiovascular event risk has prompted ...
The AI model will help “clinicians to accurately identify” coronary microvascular dysfunction (CMVD), which is hard to diagnose during ER visits.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback